# Mayoly

> family, pharma, dermocosmetics, international

Business model and tags: B2B, B2C, Manufacturing, Multi-product, Pharma & life sciences, Family-owned, International operations, Has production sites, Has in-house R&D, Has a works council

## About Mayoly

Family-owned, independent, French pharmaceutical and dermatological laboratory with international operations, focused on gastroenterology and dermocosmetics, aiming for consumer healthcare leadership.

## Key facts

- **Industry**: Pharmaceutical Manufacturing
- **Company size**: 1,001–5,000 employees
- **Headquarters**: Rueil-Malmaison, Île-de-France, France
- **Founded**: 1909
- **Revenue**: €14.4M (FY2025, filed accounts, INPI)
- **SIREN**: [702012980](https://annuaire-entreprises.data.gouv.fr/entreprise/702012980)
- **Website**: [mayoly.com](mayoly.com)
- **LinkedIn**: [linkedin.com/company/mayoly](https://www.linkedin.com/company/mayoly)

## Jobs at Mayoly

- [APAC Growth & Portfolio Expansion Strategist](https://www.linkedin.com/jobs/view/4487195677/) · Bar-sur-Aube, Grand Est, France · Nov 9, 2026
- [APAC Growth & Portfolio Expansion Leader](https://www.linkedin.com/jobs/view/4486220372/) · Bar-sur-Aube, Grand Est, France · Nov 6, 2026
- [Responsable Commercial Marketing Export / Diagnostics PHARMA - H/F](https://www.linkedin.com/jobs/view/4469341196/) · Rueil-Malmaison, Île-de-, France · Sep 23, 2026

[See all 4 openings](https://www.tamtam.ai/c/mayoly/jobs)

## Mayoly in the news

- [Mayoly : « Le contrat-cadre est aussi un avantage pour les cabinets »](https://www.republikgroup.com/articles/098f4851-2a81-f111-b337-000d3a3a1397/mayoly--le-contrat-cadre-est-aussi-un-avantage-pour-les-cabinets-) · republikgroup.com · Jul 18, 2026
  Mayoly optimized its intellectual services purchasing after the Ipsen CHC acquisition, structuring supplier categories, implementing framework agreements, and reducing off-contract spending by providing internal stakeholders with better tools and support.
- [INDUSTRIE : Le groupe pharmaceutique Mayoly relocalise la production de colchicine à Auxerre](https://www.autun-infos.com/news/bourgogne-franche-comte/bourgogne-franche-comte/industrie-le-groupe-pharmaceutique-mayoly-relocalise-la-production-de-colchicine-a-auxerre-1782252000.html) · autun-infos.com · Jun 26, 2026
  Mayoly is relocating colchicine production from Eastern Europe to Auxerre, France, partnering with Galien.
- [Un médicament "stratégique" contre la goutte relocalisé en France](https://www.macommune.info/un-medicament-strategique-contre-la-goutte-relocalise-en-france/) · macommune.info · Jun 26, 2026
  Mayoly relocated the production of colchicine, an essential gout medication, to France with significant investment, despite higher costs, to ensure national supply and reduce foreign dependency.

[See all 20 articles](https://www.tamtam.ai/c/mayoly/news)

## Mayoly at a glance

Mayoly is a B2B/B2C company in the Pharmaceutical Manufacturing industry, headquartered in Rueil-Malmaison, Île-de-France, France.

Mayoly was founded in 1909.

Mayoly has 1,001–5,000 employees.

Mayoly's revenue is €14.4M (FY2025, filed accounts, INPI).

Mayoly's SIREN number is 702012980.

Mayoly is hiring: 4 recent open roles, including APAC Growth & Portfolio Expansion Strategist, APAC Growth & Portfolio Expansion Leader, Responsable Commercial Marketing Export / Diagnostics PHARMA - H/F.

## Frequently asked questions about Mayoly

### What is Mayoly's revenue?

Mayoly's revenue is €14.4M (FY2025, filed accounts, INPI).

### How many employees does Mayoly have?

Mayoly has 1,001–5,000 employees.

### Where is Mayoly headquartered?

Mayoly is headquartered in Rueil-Malmaison, Île-de-France, France.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/mayoly
